FdaApplication
BLA 761111
Identifiers
- fda_app_no: BLA761111
Properties
| Property | Value |
|---|---|
| applicant_name | Hospira Inc., a Pfizer Company |
| application_type | BLA |
| approval_date | 2020-06-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NYVEPRIA | PEGFILGRASTIM-APGF | 6MG/0.6ML | Injection |
1 product